Top Markets
Coin of the day
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940
株式のランク #519
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
株価
$1,071.12
時価総額
$49.58B
変化(1日)
-3.73%
変化(1年)
-5.56%
KR
取引 Samsung Biologics Co.,Ltd. (207940)

カテゴリー

Samsung Biologics Co.,Ltd.(207940)の株式分割履歴
Samsung Biologics Co.,Ltd.株(シンボル:207940)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 12, 2026に行われました。
Aug 12, 2026より前に購入された207940株は、現在0207940株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
CH
0 -
BE
1 x3
AU